Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA022794-20
Application #
2087097
Study Section
Pathology A Study Section (PTHA)
Project Start
1978-02-01
Project End
1998-03-31
Budget Start
1996-04-03
Budget End
1998-03-31
Support Year
20
Fiscal Year
1996
Total Cost
Indirect Cost

  Institution

Name
Children's Hospital of Los Angeles
Department
Type
DUNS #
094878337
City
Los Angeles
State
CA
Country
United States
Zip Code
90027

  Publications

Metelitsa, Leonid S; Wu, Hong-Wei; Wang, Hong et al. (2004) Natural killer T cells infiltrate neuroblastomas expressing the chemokine CCL2. J Exp Med 199:1213-21
Shimada, Hiroyuki; Nakagawa, Atsuko; Peters, Julius et al. (2004) TrkA expression in peripheral neuroblastic tumors: prognostic significance and biological relevance. Cancer 101:1873-81
Metelitsa, L S; Weinberg, K I; Emanuel, P D et al. (2003) Expression of CD1d by myelomonocytic leukemias provides a target for cytotoxic NKT cells. Leukemia 17:1068-77
Loza, Matthew J; Metelitsa, Leonid S; Perussia, Bice (2002) NKT and T cells: coordinate regulation of NK-like phenotype and cytokine production. Eur J Immunol 32:3453-62
Rudnick, E; Khakoo, Y; Antunes, N L et al. (2001) Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: clinical outcome and antineuronal antibodies-a report from the Children's Cancer Group Study. Med Pediatr Oncol 36:612-22
Metelitsa, L S; Naidenko, O V; Kant, A et al. (2001) Human NKT cells mediate antitumor cytotoxicity directly by recognizing target cell CD1d with bound ligand or indirectly by producing IL-2 to activate NK cells. J Immunol 167:3114-22
Perez, C A; Matthay, K K; Atkinson, J B et al. (2000) Biologic variables in the outcome of stages I and II neuroblastoma treated with surgery as primary therapy: a children's cancer group study. J Clin Oncol 18:18-26
Seeger, R C; Reynolds, C P; Gallego, R et al. (2000) Quantitative tumor cell content of bone marrow and blood as a predictor of outcome in stage IV neuroblastoma: a Children's Cancer Group Study. J Clin Oncol 18:4067-76
Nickerson, H J; Matthay, K K; Seeger, R C et al. (2000) Favorable biology and outcome of stage IV-S neuroblastoma with supportive care or minimal therapy: a Children's Cancer Group study. J Clin Oncol 18:477-86
DuBois, S G; Kalika, Y; Lukens, J N et al. (1999) Metastatic sites in stage IV and IVS neuroblastoma correlate with age, tumor biology, and survival. J Pediatr Hematol Oncol 21:181-9

Showing the most recent 10 out of 47 publications